These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

658 related items for PubMed ID: 2140889

  • 1. Acylated plasminogen-streptokinase activator complex: a new approach to thrombolytic therapy.
    Crabbe SJ, Grimm AM, Hopkins LE.
    Pharmacotherapy; 1990; 10(2):115-26. PubMed ID: 2140889
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Effects of anistreplase on coronary patency in acute myocardial infarction].
    Pacouret G, Charbonnier B.
    Arch Mal Coeur Vaiss; 1990 Feb; 83 Spec No 1():25-9. PubMed ID: 2108643
    [Abstract] [Full Text] [Related]

  • 4. [New thrombolytic agents in myocardial infarction].
    Charbonnier B, Lang M, Brochier M.
    Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
    [Abstract] [Full Text] [Related]

  • 5. [The new thrombolytic agents].
    Bassand JP.
    Ann Cardiol Angeiol (Paris); 1989 Sep 30; 38(7 Pt 2):487-91. PubMed ID: 2511796
    [Abstract] [Full Text] [Related]

  • 6. Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinase.
    Anderson JL, Rothbard RL, Hackworthy RA, Sorensen SG, Fitzpatrick PG, Dahl CF, Hagan AD, Browne KF, Symkoviak GP, Menlove RL.
    J Am Coll Cardiol; 1988 Jun 30; 11(6):1153-63. PubMed ID: 3284943
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Development and evaluation of anisoylated plasminogen streptokinase activator complex (APSAC) as a second generation thrombolytic agent.
    Anderson JL.
    J Am Coll Cardiol; 1987 Nov 30; 10(5 Suppl B):22B-27B. PubMed ID: 3312369
    [Abstract] [Full Text] [Related]

  • 9. Coronary thrombolysis with clot-selective plasminogen activators.
    Collen D, Bounameaux H.
    Herz; 1986 Feb 30; 11(1):9-15. PubMed ID: 3082731
    [Abstract] [Full Text] [Related]

  • 10. [Comparison of clinical efficacy of thrombolytic drugs in patients with acute myocardial infarction].
    López-Sendón JL.
    Rev Esp Cardiol; 1992 Feb 30; 45 Suppl 2():9-20. PubMed ID: 1475514
    [Abstract] [Full Text] [Related]

  • 11. An interim report of the efficacy and safety of anisoylated plasminogen streptokinase activator complex (APSAC).
    Johnson ES, Cregeen RJ.
    Drugs; 1987 Feb 30; 33 Suppl 3():298-311. PubMed ID: 3315612
    [Abstract] [Full Text] [Related]

  • 12. New developments in thrombolytic therapy.
    Collen D, Gold HK.
    Adv Exp Med Biol; 1990 Feb 30; 281():333-54. PubMed ID: 2129372
    [Abstract] [Full Text] [Related]

  • 13. Tolerance and complications in a multicenter trial of intravenous APSAC and intracoronary streptokinase in acute myocardial infarction.
    Rothbard RL, Anderson JL, Fitzpatrick PG, Hakworthy RA, Sorensen SG, Marder VJ.
    Clin Cardiol; 1990 Mar 30; Suppl 5():V11-4; discussion V27-32. PubMed ID: 2182234
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Thrombolytic treatment in acute myocardial infarction.
    Verstraete M.
    Circulation; 1990 Sep 30; 82(3 Suppl):II96-109. PubMed ID: 2118432
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.